SrasV1, PubMed, Checkpoint, bibRecord, 001313

Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Identifieur interne : 001313 ( PubMed/Checkpoint ); précédent : 001312; suivant : 001314

Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Auteurs : Candice Clay [États-Unis] ; Nathan Donart ; Ndingsa Fomukong ; Jennifer B. Knight ; Wanli Lei ; Lance Price ; Fletcher Hahn ; Jesse Van Westrienen ; Kevin S. Harrod

Source :

Journal of virology [ 1098-5514 ] ; 2012.

RBID : pubmed:22345460

Descripteurs français

English descriptors

KwdEn :
- Animals, Antibodies, Viral (immunology), Cell Line, Chlorocebus aethiops, Coronavirus (immunology), Cytokines (metabolism), Dendritic Cells (immunology), Humans, Immunoglobulin A (immunology), Immunoglobulin G (immunology), Lung (immunology), Lung (pathology), Lung (virology), Macrophage Activation (immunology), Macrophages (immunology), Membrane Glycoproteins (immunology), Monocytes (immunology), Pneumonia (immunology), Pneumonia (pathology), Pneumonia (virology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (metabolism), Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus, T-Lymphocytes (immunology), Viral Envelope Proteins (immunology), Virus Replication.
MESH :
- chemical , immunology : Antibodies, Viral, Immunoglobulin A, Immunoglobulin G, Membrane Glycoproteins, Viral Envelope Proteins.
- immunology : Coronavirus, Dendritic Cells, Lung, Macrophage Activation, Macrophages, Monocytes, Pneumonia, Severe Acute Respiratory Syndrome, T-Lymphocytes.
- chemical , metabolism : Cytokines, Severe Acute Respiratory Syndrome.
- pathology : Lung, Pneumonia.
- virology : Lung, Pneumonia, Severe Acute Respiratory Syndrome.
- Animals, Cell Line, Chlorocebus aethiops, Humans, Spike Glycoprotein, Coronavirus, Virus Replication.

Abstract

Our knowledge regarding immune-protective and immunopathogenic events in severe acute respiratory syndrome coronavirus (SARS-CoV) infection is limited, and little is known about the dynamics of the immune response at the primary site of disease. Here, an African green monkey (AGM) model was used to elucidate immune mechanisms that facilitate viral clearance but may also contribute to persistent lung inflammation following SARS-CoV infection. During primary infection, SARS-CoV replicated in the AGM lung for up to 10 days. Interestingly, lung inflammation was more prevalent following viral clearance, as leukocyte numbers peaked at 14 days postinfection (dpi) and remained elevated at 28 dpi compared to those of mock-infected controls. Lung macrophages but not dendritic cells were rapidly activated, and both cell types had high activation marker expression at late infection time points. Lung proinflammatory cytokines were induced at 1 to 14 dpi, but most returned to baseline by 28 dpi except interleukin 12 (IL-12) and gamma interferon. In SARS-CoV homologous rechallenge studies, 11 of the 12 animals were free of replicating virus at day 5 after rechallenge. However, incidence and severity of lung inflammation was not reduced despite the limited viral replication upon rechallenge. Evaluating the role of antibodies in immune protection or potentiation revealed a progressive increase in anti-SARS-CoV antibodies in lung and serum that did not correlate temporally or spatially with enhanced viral replication. This study represents one of the first comprehensive analyses of lung immunity, including changes in leukocyte populations, lung-specific cytokines, and antibody responses following SARS-CoV rechallenge in AGMs.

DOI: 10.1128/JVI.06791-11
PubMed: 22345460

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001396
to stream PubMed, to step Curation: 001396

Links to Exploration step

pubmed:22345460

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.</title>
<author><name sortKey="Clay, Candice" sort="Clay, Candice" uniqKey="Clay C" first="Candice" last="Clay">Candice Clay</name>
<affiliation wicri:level="2"><nlm:affiliation>Lovelace Respiratory Research Institute, Infectious Disease Program, Albuquerque, New Mexico, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Lovelace Respiratory Research Institute, Infectious Disease Program, Albuquerque, New Mexico</wicri:regionArea>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donart, Nathan" sort="Donart, Nathan" uniqKey="Donart N" first="Nathan" last="Donart">Nathan Donart</name>
</author>
<author><name sortKey="Fomukong, Ndingsa" sort="Fomukong, Ndingsa" uniqKey="Fomukong N" first="Ndingsa" last="Fomukong">Ndingsa Fomukong</name>
</author>
<author><name sortKey="Knight, Jennifer B" sort="Knight, Jennifer B" uniqKey="Knight J" first="Jennifer B" last="Knight">Jennifer B. Knight</name>
</author>
<author><name sortKey="Lei, Wanli" sort="Lei, Wanli" uniqKey="Lei W" first="Wanli" last="Lei">Wanli Lei</name>
</author>
<author><name sortKey="Price, Lance" sort="Price, Lance" uniqKey="Price L" first="Lance" last="Price">Lance Price</name>
</author>
<author><name sortKey="Hahn, Fletcher" sort="Hahn, Fletcher" uniqKey="Hahn F" first="Fletcher" last="Hahn">Fletcher Hahn</name>
</author>
<author><name sortKey="Van Westrienen, Jesse" sort="Van Westrienen, Jesse" uniqKey="Van Westrienen J" first="Jesse" last="Van Westrienen">Jesse Van Westrienen</name>
</author>
<author><name sortKey="Harrod, Kevin S" sort="Harrod, Kevin S" uniqKey="Harrod K" first="Kevin S" last="Harrod">Kevin S. Harrod</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22345460</idno>
<idno type="pmid">22345460</idno>
<idno type="doi">10.1128/JVI.06791-11</idno>
<idno type="wicri:Area/PubMed/Corpus">001396</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001396</idno>
<idno type="wicri:Area/PubMed/Curation">001396</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001396</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001313</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001313</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.</title>
<author><name sortKey="Clay, Candice" sort="Clay, Candice" uniqKey="Clay C" first="Candice" last="Clay">Candice Clay</name>
<affiliation wicri:level="2"><nlm:affiliation>Lovelace Respiratory Research Institute, Infectious Disease Program, Albuquerque, New Mexico, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Lovelace Respiratory Research Institute, Infectious Disease Program, Albuquerque, New Mexico</wicri:regionArea>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donart, Nathan" sort="Donart, Nathan" uniqKey="Donart N" first="Nathan" last="Donart">Nathan Donart</name>
</author>
<author><name sortKey="Fomukong, Ndingsa" sort="Fomukong, Ndingsa" uniqKey="Fomukong N" first="Ndingsa" last="Fomukong">Ndingsa Fomukong</name>
</author>
<author><name sortKey="Knight, Jennifer B" sort="Knight, Jennifer B" uniqKey="Knight J" first="Jennifer B" last="Knight">Jennifer B. Knight</name>
</author>
<author><name sortKey="Lei, Wanli" sort="Lei, Wanli" uniqKey="Lei W" first="Wanli" last="Lei">Wanli Lei</name>
</author>
<author><name sortKey="Price, Lance" sort="Price, Lance" uniqKey="Price L" first="Lance" last="Price">Lance Price</name>
</author>
<author><name sortKey="Hahn, Fletcher" sort="Hahn, Fletcher" uniqKey="Hahn F" first="Fletcher" last="Hahn">Fletcher Hahn</name>
</author>
<author><name sortKey="Van Westrienen, Jesse" sort="Van Westrienen, Jesse" uniqKey="Van Westrienen J" first="Jesse" last="Van Westrienen">Jesse Van Westrienen</name>
</author>
<author><name sortKey="Harrod, Kevin S" sort="Harrod, Kevin S" uniqKey="Harrod K" first="Kevin S" last="Harrod">Kevin S. Harrod</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Coronavirus (immunology)</term>
<term>Cytokines (metabolism)</term>
<term>Dendritic Cells (immunology)</term>
<term>Humans</term>
<term>Immunoglobulin A (immunology)</term>
<term>Immunoglobulin G (immunology)</term>
<term>Lung (immunology)</term>
<term>Lung (pathology)</term>
<term>Lung (virology)</term>
<term>Macrophage Activation (immunology)</term>
<term>Macrophages (immunology)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Monocytes (immunology)</term>
<term>Pneumonia (immunology)</term>
<term>Pneumonia (pathology)</term>
<term>Pneumonia (virology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>T-Lymphocytes (immunology)</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation des macrophages (immunologie)</term>
<term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Cellules dendritiques (immunologie)</term>
<term>Coronavirus (immunologie)</term>
<term>Cytokines (métabolisme)</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Humains</term>
<term>Immunoglobuline A (immunologie)</term>
<term>Immunoglobuline G (immunologie)</term>
<term>Lignée cellulaire</term>
<term>Lymphocytes T (immunologie)</term>
<term>Macrophages (immunologie)</term>
<term>Monocytes (immunologie)</term>
<term>Pneumopathie infectieuse (anatomopathologie)</term>
<term>Pneumopathie infectieuse (immunologie)</term>
<term>Pneumopathie infectieuse (virologie)</term>
<term>Poumon (anatomopathologie)</term>
<term>Poumon (immunologie)</term>
<term>Poumon (virologie)</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Réplication virale</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (métabolisme)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Immunoglobulin A</term>
<term>Immunoglobulin G</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Pneumopathie infectieuse</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Activation des macrophages</term>
<term>Anticorps antiviraux</term>
<term>Cellules dendritiques</term>
<term>Coronavirus</term>
<term>Glycoprotéines membranaires</term>
<term>Immunoglobuline A</term>
<term>Immunoglobuline G</term>
<term>Lymphocytes T</term>
<term>Macrophages</term>
<term>Monocytes</term>
<term>Pneumopathie infectieuse</term>
<term>Poumon</term>
<term>Protéines de l'enveloppe virale</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus</term>
<term>Dendritic Cells</term>
<term>Lung</term>
<term>Macrophage Activation</term>
<term>Macrophages</term>
<term>Monocytes</term>
<term>Pneumonia</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytokines</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytokines</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term>
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Pneumopathie infectieuse</term>
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Lung</term>
<term>Pneumonia</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Réplication virale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Our knowledge regarding immune-protective and immunopathogenic events in severe acute respiratory syndrome coronavirus (SARS-CoV) infection is limited, and little is known about the dynamics of the immune response at the primary site of disease. Here, an African green monkey (AGM) model was used to elucidate immune mechanisms that facilitate viral clearance but may also contribute to persistent lung inflammation following SARS-CoV infection. During primary infection, SARS-CoV replicated in the AGM lung for up to 10 days. Interestingly, lung inflammation was more prevalent following viral clearance, as leukocyte numbers peaked at 14 days postinfection (dpi) and remained elevated at 28 dpi compared to those of mock-infected controls. Lung macrophages but not dendritic cells were rapidly activated, and both cell types had high activation marker expression at late infection time points. Lung proinflammatory cytokines were induced at 1 to 14 dpi, but most returned to baseline by 28 dpi except interleukin 12 (IL-12) and gamma interferon. In SARS-CoV homologous rechallenge studies, 11 of the 12 animals were free of replicating virus at day 5 after rechallenge. However, incidence and severity of lung inflammation was not reduced despite the limited viral replication upon rechallenge. Evaluating the role of antibodies in immune protection or potentiation revealed a progressive increase in anti-SARS-CoV antibodies in lung and serum that did not correlate temporally or spatially with enhanced viral replication. This study represents one of the first comprehensive analyses of lung immunity, including changes in leukocyte populations, lung-specific cytokines, and antibody responses following SARS-CoV rechallenge in AGMs.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22345460</PMID>
<DateCompleted><Year>2012</Year>
<Month>06</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>86</Volume>
<Issue>8</Issue>
<PubDate><Year>2012</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.</ArticleTitle>
<Pagination><MedlinePgn>4234-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.06791-11</ELocationID>
<Abstract><AbstractText>Our knowledge regarding immune-protective and immunopathogenic events in severe acute respiratory syndrome coronavirus (SARS-CoV) infection is limited, and little is known about the dynamics of the immune response at the primary site of disease. Here, an African green monkey (AGM) model was used to elucidate immune mechanisms that facilitate viral clearance but may also contribute to persistent lung inflammation following SARS-CoV infection. During primary infection, SARS-CoV replicated in the AGM lung for up to 10 days. Interestingly, lung inflammation was more prevalent following viral clearance, as leukocyte numbers peaked at 14 days postinfection (dpi) and remained elevated at 28 dpi compared to those of mock-infected controls. Lung macrophages but not dendritic cells were rapidly activated, and both cell types had high activation marker expression at late infection time points. Lung proinflammatory cytokines were induced at 1 to 14 dpi, but most returned to baseline by 28 dpi except interleukin 12 (IL-12) and gamma interferon. In SARS-CoV homologous rechallenge studies, 11 of the 12 animals were free of replicating virus at day 5 after rechallenge. However, incidence and severity of lung inflammation was not reduced despite the limited viral replication upon rechallenge. Evaluating the role of antibodies in immune protection or potentiation revealed a progressive increase in anti-SARS-CoV antibodies in lung and serum that did not correlate temporally or spatially with enhanced viral replication. This study represents one of the first comprehensive analyses of lung immunity, including changes in leukocyte populations, lung-specific cytokines, and antibody responses following SARS-CoV rechallenge in AGMs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clay</LastName>
<ForeName>Candice</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Lovelace Respiratory Research Institute, Infectious Disease Program, Albuquerque, New Mexico, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Donart</LastName>
<ForeName>Nathan</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fomukong</LastName>
<ForeName>Ndingsa</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Knight</LastName>
<ForeName>Jennifer B</ForeName>
<Initials>JB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lei</LastName>
<ForeName>Wanli</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Price</LastName>
<ForeName>Lance</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hahn</LastName>
<ForeName>Fletcher</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Van Westrienen</LastName>
<ForeName>Jesse</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Harrod</LastName>
<ForeName>Kevin S</ForeName>
<Initials>KS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>N01AI40095</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>T32 AI007538</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>02</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008262" MajorTopicYN="N">Macrophage Activation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>2</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>6</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22345460</ArticleId>
<ArticleId IdType="pii">JVI.06791-11</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.06791-11</ArticleId>
<ArticleId IdType="pmc">PMC3318632</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Biol Chem. 2007 Nov 2;282(44):32208-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17761676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2007 Oct;88(Pt 10):2740-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17872527</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Apr;82(7):3220-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18199635</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2008 Apr;133(1):20-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17499378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 May;82(9):4471-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18305050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2008 Apr 25;374(1):151-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18234270</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Nov 1;181(9):6337-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18941225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2009 Apr;83(7):3039-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19004938</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2009 Oct;5(10):e1000636</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19851468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Immunol. 2010 Oct;47(16):2575-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20667598</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2001;260:145-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11443872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Pathol. 2004 Apr;121(4):574-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15080310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 May;42(5):2043-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15131168</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 May 22;363(9422):1699-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15158632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Jun 26;363(9427):2139-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Sep 1;120(1):87-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15234813</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2004 Sep;24(3):436-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15358703</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15474494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(21):12090-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15479853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15507655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1979 Nov 29;282(5738):509-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">503230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1990 Jul 1;172(1):159-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2162904</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2004 Dec 5;330(1):8-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15527829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 2004 Oct;293(1-2):23-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15541274</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2005 Jan;107(1):93-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15567038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jan;79(1):503-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15596843</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2004 Dec;10(12):1062-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15606632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15642942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2005 Mar;11(3):411-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15757556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jun;79(12):7819-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15919935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Jun 15;174(12):7977-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15944304</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Jul 1;175(1):591-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15972696</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2005 Oct 1;106(7):2366-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15860669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16169905</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2005 Oct;128(4):2247-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16236881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2005 Nov 15;392(Pt 1):135-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16048439</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2005 Dec;5(12):917-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16322745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2006 Jan;8(1):122-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16182592</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2006 Jul;87(Pt 7):1953-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16760397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Immunol. 2006 Aug;120(2):171-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16781892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2006 Aug 1;351(2):466-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16690096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2006 Sep;71(2-3):397-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16837072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2006 Aug;8(9-10):2424-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16844400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jan;81(2):548-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17108024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Immunol. 2007;25:443-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17243893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17620608</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Aug;81(16):8692-706</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17537853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Sep;81(18):9812-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17596301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2007 Aug 10;3(8):e112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17696609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Am Thorac Soc. 2007 Dec;4(8):618-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18073393</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Nouveau-Mexique</li>
</region>
</list>
<tree><noCountry><name sortKey="Donart, Nathan" sort="Donart, Nathan" uniqKey="Donart N" first="Nathan" last="Donart">Nathan Donart</name>
<name sortKey="Fomukong, Ndingsa" sort="Fomukong, Ndingsa" uniqKey="Fomukong N" first="Ndingsa" last="Fomukong">Ndingsa Fomukong</name>
<name sortKey="Hahn, Fletcher" sort="Hahn, Fletcher" uniqKey="Hahn F" first="Fletcher" last="Hahn">Fletcher Hahn</name>
<name sortKey="Harrod, Kevin S" sort="Harrod, Kevin S" uniqKey="Harrod K" first="Kevin S" last="Harrod">Kevin S. Harrod</name>
<name sortKey="Knight, Jennifer B" sort="Knight, Jennifer B" uniqKey="Knight J" first="Jennifer B" last="Knight">Jennifer B. Knight</name>
<name sortKey="Lei, Wanli" sort="Lei, Wanli" uniqKey="Lei W" first="Wanli" last="Lei">Wanli Lei</name>
<name sortKey="Price, Lance" sort="Price, Lance" uniqKey="Price L" first="Lance" last="Price">Lance Price</name>
<name sortKey="Van Westrienen, Jesse" sort="Van Westrienen, Jesse" uniqKey="Van Westrienen J" first="Jesse" last="Van Westrienen">Jesse Van Westrienen</name>
</noCountry>
<country name="États-Unis"><region name="Nouveau-Mexique"><name sortKey="Clay, Candice" sort="Clay, Candice" uniqKey="Clay C" first="Candice" last="Clay">Candice Clay</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001313 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001313 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:22345460
   |texte=   Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:22345460" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki